In this review:
This article reviews the use of budesonide/eformoterol (Symbicort®) in the treatment of patients with
chronic obstructive pulmonary disease (COPD) with regard to exacerbations, morning symptoms,
pneumonia risk, and treatment response, and with an emphasis on real-world evidence.
Download PDF